Several previous studies have reported the involvement of Rab3B in hepatocellular carcinoma, glioma, breast cancer, and prostate cancer (Tsunedomi et al. 2022; Liu et al. 2014; Ye et al. 2014; Tan et al. 2012). Here, RAB3B is linked to prostate cancer.